42
DAFTAR PUSTAKA
Akturk, E., Karaca, R.,E., Alanbay, I., Dede, M., Yenen, M., Baser, I., 2011.
Comparison of four malignancy risk indices in the detection of malignant
ovarian masses. J Gynrcol Oncol. 2011 Sep; 22(3): 177-182
American Cancer Society, 2014. Ovarium Cancer. Available from :
http://www.ovariancancer.org. [ August 8, 2014].
Anastasi, E., Granato, T., Falzarano, R., Storelli, P., Ticino, A., Frati, L., Panici, P.B.,
Porpora, M.G., 2013. The use of HE4,CA125, and CA72-4 biomarkers for
differential duagnosis between ovarian endometrioma and epithelial ovarian
cancer. Journal of ovarian Research 2013, 6:44
Anwar, M., et al., 2011. Ilmu Kandungan. Edisi 3. Jakarta: Tridasa Printer. 307-31
Arania, R., Windarti, I., 2015. Karakteristik Pasien Kanker Ovarium Di Rumah Sakit
Dr.H.Abdul Moeloek Bandar Lampung Tahun 2009-2013. Juke Unila,
Volume 5, Nomor 9, Maret 2015.
Aziz, M.F., et al., 2006. Buku Acuan Nasional Onkologi Ginecologi. Edisi 6. Jakarta:
Yayasan Bina Pustaka Sarwono Prawirohardjo FKUI. 468-527
Bouzari, M., Yazdani, M.H., Barat, S., Kelagar, Z.S., Kutenaia, M.J., Abbaszade, N.,
Khajat, F., 2011. BMC Research Notes 2011,4:206
DiSaia, P.J., et al., 2007. Clinical Gynecology Oncology. Epithelial Ovarian Cancer.
11: 313-359.
Fader, A.,N., Java, J., Krivak, T.,C., Bristow, R., E., Tergas, A.,I., Bookman, M.,A.,
Armstrong, D.,K., Tanner, E.,J., Gershenson, D.,M., 2014. The prognostic
significance of pre- and post-treatment CA-125 in grade 1 serous ovarian
carcinoma: A Gynecologic Oncology Group study.
Geomini, P., Kruitwagen, R., Bremer, G.L., Cnossen, J., Mol, B.W.J., 2009. The
Accuracy of Risk Scores in Predicting Ovarian Malignancy. American
College of Obstetricians and Gynecologists Vol. 113, No. 2, Part 1
43
Guidelines Committee Royal College of Obstetricians and Gynaecologists and the
British Society 2014. RCOG Green-top Guideline No. 62
Hoskins., et al., 2005. Principles and practice of Gynecology oncology. Epithelial
Ovarian Cancer. 25 : 895-923.
Irhsad, F., Irhsad, M., Naz, M., Ikram, M.A.,2013.Accuracy of Risk of Malignancy
Indexs in the Preoperative Diagnosis of Zovarian Malignancy in Post
Menopausal Women. Rawal Medical Journal : Vol.38. No. 3
Johari, A., Siregar, F., 2013. Insidensi Kanker Ovarium Berdasarkan Faktor Resiko di
RSUP HAM Tahun 2008-2011. E-Journal FK USU volume 1 no 1 tahun 2013
Marpaung, Johny., 2007. Ketepatan Human Kallikrein 6 sebagai prediksi keganasan
ovarium dibandingkan dengan Ca 125. USU e-Repository 2008
Manuaba, I. A.C., Manuaba, I.B.G., Manuaba, I.B.F., 2010. Buku Ajar Penuntun
Kuliah Ginekologi. 8: 517-553.
Marpaung, J., 2007. Ketepatan human kallikrein 6 sebagai prediksi keganasan
dibandingkan dengan Ca 125. Usu e-repository 2008
Mulawahardhana, P., Askandar, B., Soehatno, 2011. Perbandingan antara HE4, Ca
125, dan kombinasi HE4 & Ca 125 sebagai tumor marker pada pasien kanker
ovarium tipe epitel. Majalah obstetri&ginekologi, Vol. 19 No. 2 Mei-Agustus
2011: 81-87
Nucci,M., Olivia, E., 2008. Gynecologic Pathology Foundation in Diagnostic
Pathology series. Boston :Elsevier churchill livingstone
Ovarian cancer 2014 report. Available at
http://www.dietandcancerreport.org/cup/cup resources.php. [Accessed
December 2013].
Shih, L.M., Kurman, R.J., 2004. Ovarian Tumorigenesis Aproposed Model Based on
Morphological and Molecular Genetic Analysis. American Journal of
Pathology, Vol. 164, No. 5
Simsek, H.S., Tokmak, A., Ozgu, E., Doganay, M., Danisman, N., Erkaya, S.,
Gungor, T., 2014. Role of a Risk of Malignancy Index in Clinical Approaches
44
to Adnexal Masses. Asian Pasific Journal of Cancer Prevention. Vol 15,
2014.
Thakur, V., Anand, A.K., Mukherjee, U., Ghosh, D., 2003. Determination of cancer
antigen 125 in ovarian carcinoma. Indian Journal of Clinical Biochemistry,
2003, 18 (2) 27-33
Torres, J.C.C., Derchain, S.F.M., Faundes, A., Gontijo, R.C.,Martinez, E.Z., Andrade,
L., 2002 Risk of Malignancy Index in preoperative evaluation of clinically
restricted ovarian cancer. Sao Paulo Med J/Rev Paul Med 2002;120(3):72-6
T, Malati., 2007. Tumour Marker: An Overview. Indian journal of clinical
biochemistry, 2007 /22 (2) 17-31.
WHO 2014. Breast and Female Genital. Tumours of the ovary. 1 : 13-40
